← Back to catalogue

LIAISON® Biotrin Control Parvovirus B19 IgG Plus

FDA UDI

Class III (US FDA UDI)

by Diasorin Inc.

Identity

Trade Name
LIAISON® Biotrin Control Parvovirus B19 IgG Plus FDA UDI
Generic Name
Parvovirus B19 immunoglobulin G (IgG) antibody IVD, control FDA UDI
Device Name
Italy manufactured kit. FDA UDI
Model / Reference
311551 FDA UDI
Description
Italy manufactured kit. FDA UDI

Identifiers

Primary DI / UDI-DI
08056771104036 FDA UDI
PMA Number
P220034 FDA UDI
FDA Product Code
MYL FDA UDI
GMDN Term
Parvovirus B19 immunoglobulin G (IgG) antibody IVD, control FDA UDI

Classification

Device Class
Class III FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Parvovirus B19 immunoglobulin G (IgG) antibody IVD, control

LIAISON® Biotrin Control Parvovirus B19 IgG Plus by Diasorin Inc. — Class III — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Diasorin Inc.

Sources (1)

  • FDA UDI 43f06767-2d03-49e4-82e0-0838987fa52e 34 fields · synced May 30, 2026